Rhoda Sperling

Rhoda Sperling, MD is a Clinical Professor in the Department of Obstetrics and Gynecology at the Icahn School of Medicine at Mount Sinai, specializing in maternal-fetal medicine with dual expertise in infectious diseases.

Education:

• MD, University of Chicago Pritzker School of Medicine
• Residency in Obstetrics & Gynecology, Mount Sinai Hospital
• Fellowship in Infectious Disease, Mount Sinai Services City Hospital of Elmhurst
• Fellowship in Infectious Disease, University of Texas Health Science Center

Certifications:

• American Board of Obstetrics and Gynecology

Dr. Sperling's research bridges obstetrics, hepatology, and infectious disease, focusing on how metabolic conditions like nonalcoholic fatty liver disease (NAFLD) impact pregnancy outcomes and how infectious diseases including SARS-CoV-2 affect maternal-fetal health. Her work combines clinical practice with rigorous scientific investigation to address critical gaps in maternal-fetal medicine.

Research Trends:

Analysis of Dr. Sperling's recent publications reveals a strategic research trajectory examining the intersection of metabolic health and infectious disease in pregnancy. Her work has evolved from characterizing NAFLD prevalence in pregnant populations (2021), to evaluating long-term infant outcomes (2022), and most recently investigating immune responses to emerging pathogens like SARS-CoV-2 (2023). This progression demonstrates both methodological sophistication and responsiveness to pressing public health challenges.

Professional Impact:

• Author of 130+ publications in high-impact medical journals
• Principal investigator on studies addressing critical maternal health conditions
• Contributor to clinical guidelines on infectious disease management in pregnancy
• Collaborator with multidisciplinary research teams across institutions